Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Year in Review: Prostate Cancer - 2024 Insights and Exciting Prospec…

Jason Hafron

Year in Review - Prostate Cancer

Oncology 2024 Year in Review

K. Tawagi

Year in Review 2024 - Colorectal Cancer

Oncology 2024 Year in Review

R. Kim, T. Biachi

Year in Review 2024 - Managing Advanced Prostate Cancer

Oncology 2024 Year in Review

R. Dreicer

Year in Review - Key Clinical Trials in Prostate Cancer

GWU Urology

Year in Review: Cutting Edge Advances in Kidney Cancer - Imaging and…

Ketan Badani

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC

Advanced Prostate Cancer Consensus Conference (APCCC)

K. Fizazi

Hot Flashes: Nonhormonal Options for Cancer Patients

Stanford Medicine

M. Dolezal

SABCS 2024 Summary: Addressing Pathologic and Therapeutic Challenges…

2024 SABCS Annual Meeting Insights Hub

L. Tabar

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

Spinal Tumor Ablation and Vertebral Augmentation in Cancer Patients

Douglas Beall

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer

University of Illinois Cancer Center

K. Tawagi, N. Reizine

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

Year in Review 2024 - Renal Cell Carcinoma

Oncology 2024 Year in Review

N. Mar

Advanced Prostate Cancer Therapy: Effective and Minimally Invasive

DrTalks

M. Hong

ASCO® GI 2025 Insights: Trifluridine/Tipiracil vs. Placebo in Patien…

Insights from 2025 ASCO® GI Annual Meeting

H. Bando